Skip to main content
Toggle navigation
Login
Search
Home
Back
Favorite
0
Like
Facebook
Print
OCPC
Antibody Therapies: A New Path Forward in the Treatment of R/R Multiple Myeloma
Friday, October 14, 2022
3:55 PM – 4:40 PM
Learning Objectives:
Summarize the latest clinical efficacy and safety data of new and emerging antibody therapies for MM
Assess clinical guidelines and pathways in the context of incorporating antibody therapies into the MM treatment landscape
Integrate therapeutic advances, formulary, and cost considerations into MM clinical pathways discussions